Compare Charles River Laboratories Intl. Inc (CRL) vs Iron Mountain Inc (IRM) Price & Performance

Charles River Laboratories (CRL) trades at $298.00, down 0.77% on the day, with a bullish technical signal supported by moving averages. The company has beaten earnings estimates for three consecutive quarters, though it reported a net loss of -$144.34M for 2025. Analyst consensus is strongly positive with a $305.50 price target, and recent news highlights a strategic growth plan targeting 5%-7% revenue growth by 2030.

The stock's outlook is supported by strong analyst buy ratings and a clear growth strategy, but faces risks from negative profitability metrics and high valuation multiples. Investment opportunity hinges on successful execution of margin expansion and cost savings initiatives, while key risks include persistent net losses and competitive pressures in the healthcare services sector.

Iron Mountain (IRM) trades at $112.97, down 2.38% with a bearish technical signal. The company shows strong revenue growth from $6.9B in 2025 to $7.6B projected for 2026, though net margins remain thin at 2.09%. Recent earnings beats and a 300MW data center pipeline expansion highlight growth initiatives. Analyst consensus is bullish with a $142.75 price target, representing 26% upside potential from current levels.

IRM offers compelling growth in data center and digital services but carries significant debt risk with 79.04% debt-to-asset ratio. The stock presents opportunity for investors seeking exposure to digital infrastructure expansion, though high leverage and thin margins require careful monitoring. Current technical weakness may provide entry points for long-term investors aligned with analyst optimism.